Publications by authors named "Brigitte Schott"

Claim this Profile
Q
Quadruple space-group ambiguity owing to rotational and translational noncrystallographic symmetry in human liver fructose-1,6-bisphosphatase.
Armin Ruf, Tim Tetaz, Brigitte Schott, Catherine Joseph, Markus G Rudolph

Acta Crystallogr D Struct Biol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.
Santhosh Kumar Vr, Murthy N Darisipudi, Stefanie Steiger, Satish Kumar Devarapu, Maia Tato, Brigitte Schott

J Am Soc Nephrol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.
Wenjun Ju, Viji Nair, Shahaan Smith, Li Zhu, Kerby Shedden, Brigitte Schott

Sci Transl Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming.
Khader Valli Rupanagudi, Onkar P Kulkarni, Julia Lichtnekert, Murthy Narayana Darisipudi, Shrikant R Mulay, Brigitte Schott

Ann Rheum Dis· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.
Paul Hebeisen, Wolfgang Haap, Bernd Kuhn, Peter Mohr, Hans Peter Wessel, Brigitte Schott

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetes.
Eric Kitas, Peter Mohr, Bernd Kuhn, Paul Hebeisen, Hans Peter Wessel, Brigitte Schott

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites.
Paul Hebeisen, Bernd Kuhn, Philipp Kohler, Marcel Gubler, Walter Huber, Brigitte Schott

Bioorg Med Chem Lett· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis